Home / Health / Plasma Infusion Offers Hope for Breast Cancer Survivors
Plasma Infusion Offers Hope for Breast Cancer Survivors
20 Nov
Summary
- Plasma infusions may alleviate genital and urinary symptoms for breast cancer survivors.
- Nearly all participants in a pilot study reported symptom improvement within six months.
- A phase 2 trial will compare plasma injections against a placebo for symptom relief.
Breast cancer survivors experiencing severe genitourinary symptoms while on hormone-blocking medication may find relief through plasma infusions. These symptoms, including vaginal dryness, itching, and pain during sex, affect up to 70% of survivors and can lead to premature discontinuation of vital cancer therapy, potentially worsening outcomes. Early findings from a pilot study indicate that platelet-rich plasma injections were highly effective.
Researchers reported that nearly all participants in the small study experienced significant improvement in genitourinary syndrome of menopause (GSM) symptoms after six months. This included enhancements in sexual function, urinary health, and overall quality of life, even while continuing estrogen-blocking treatments. The positive results suggest a strong patient desire for effective, non-hormonal solutions to this often underreported condition.
Given the promising outcomes, a phase 2 clinical trial is planned to further evaluate platelet-rich plasma injections against a placebo. The study’s success in treating GSM symptoms without interrupting breast cancer treatment or causing recurrence offers substantial hope for improving the long-term well-being of breast cancer survivors. This research highlights a novel approach to managing a common and distressing side effect of cancer therapy.
